Resistance Improvement and Sensitivity Enhancement of Cancer Therapy by a Novel Antitumor Candidate onto A2780 CP and A2780 S Cell Lines

CONCLUSIONS: As a result, PBPD is a promising anticancer agent for CDDP-resistant ovarian cancer.PMID:38618266 | PMC:PMC11015932 | DOI:10.61186/rbmb.12.3.374

Source: Mol Biol Cell - April 15, 2024 Category: Molecular Biology Authors: Sariyeh Mohammadi Hadloo Homa Mohseni Kouchesfahani Ali Khanlarkhani Maryam Saeidifar Source Type: research